Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Measurement of thrombosis and its prevention.

× No keyword cloud information.

19 in total

1. Redefinition of myocardial infarction by a consensus dissenter.

Authors: H Tunstall-Pedoe
Journal: J Am Coll Cardiol Date: 2001-04 Impact factor: 24.094

2. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease.

Authors: J Danesh; R Collins; R Peto; G D Lowe
Journal: Eur Heart J Date: 2000-04 Impact factor: 29.983

3. Who should take aspirin for primary prophylaxis of coronary heart disease?

Authors: G D Lowe
Journal: Heart Date: 2001-03 Impact factor: 5.994

4. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis.

Authors: J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; A Rumley; G D Lowe
Journal: Circulation Date: 2001-05-15 Impact factor: 29.690

5. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

Authors: J Danesh; R Collins; P Appleby; R Peto
Journal: JAMA Date: 1998-05-13 Impact factor: 56.272

Review 6. Antithrombotic strategy in stroke.

Authors: M G Bousser
Journal: Thromb Haemost Date: 2001-07 Impact factor: 5.249

Review 7. Thrombolysis in pulmonary embolism: a debatable indication.

Authors: S Z Goldhaber
Journal: Thromb Haemost Date: 2001-07 Impact factor: 5.249

8. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors: J S Alpert; K Thygesen; E Antman; J P Bassand
Journal: J Am Coll Cardiol Date: 2000-09 Impact factor: 24.094

9. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials.

Authors: G J Hankey; C L Sudlow; D W Dunbabin
Journal: Stroke Date: 2000-07 Impact factor: 7.914

10. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.

Authors: P S Sanmuganathan; P Ghahramani; P R Jackson; E J Wallis; L E Ramsay
Journal: Heart Date: 2001-03 Impact factor: 5.994

4 in total

Measurement of thrombosis and its prevention.